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Drosophila development: Scalloped and Vestigial take wing
Sarah Bray
The proteins Scalloped and Vestigial are known from
genetic studies to play a part in Drosophila wing
development. Recent results show how they interact
with each other, and in combination with other
transcription factors, to confer specific patterns of
expression within the wing. 
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What makes a wing different from a leg or an eye? Any of
us could list a variety of distinctions, but the mechanisms
that confer these characteristics during development are
less clear. In Drosophila, the progenitors of the adult
structures are the so-called ‘imaginal discs’, epithelial
discs which are set aside in the embryo, then proliferate
and differentiate during larval and pupal development
(Figure 1). Several key pathways involved in coordinat-
ing the growth and patterning of these imaginal discs
have been identified. For example, the signalling mole-
cules Hedgehog, Wingless and Decapentaplegic are
essential at several stages of wing, leg and eye develop-
ment, along with cell–cell communication mediated by
the cell-surface protein Notch. What, then, confers the
distinct responses to these signalling pathways in the
individual appendages? Three recent papers [1–3]
demonstrate the role of molecular interactions between
the Scalloped (Sd) and Vestigial (Vg) proteins in promot-
ing wing development, and indicate that a Sd–Vg
complex acts in combination with transducers of the sig-
nalling pathways to promote transcription of genes
required for wing morphogenesis [1]. 
The involvement of vestigial (vg) in Drosophila wing
development is not of itself a new story: the reduced wing
of vg mutants was first described by Thomas Hunt Morgan
in 1910 [4], and is familiar to many school-children who use
the vg mutant in their biology lessons. Ectopic vg expres-
sion is sufficient to convert cells in the eye, antenna and
leg discs to wing-like fates [5]. In this respect vg appears
analogous to Pax6/eyeless, the master switch or ‘selector
gene’ for eye development [6]. The concept of a selector
gene, as proposed by Garcia-Bellido [7], is of a switch that
assigns a cell and its progeny to one developmental
pathway. In many respects, eyeless fits the bill; its expres-
sion is unique to the eye, it is sufficient to switch other
cells to an eye fate, and it encodes a DNA-binding protein
that controls expression of genes needed for eye morpho-
genesis [6]. Although vg shares many of these properties
with respect to wing development, the protein it encodes
has a novel structure and does not contain a DNA-binding
motif [8], so its mode of action has been a mystery. 
The scalloped (sd) gene is also essential for wing develop-
ment [4]. It differs from vg, however, in that its expression
is much more widespread, being detected in other
imaginal discs and the nervous system, and its misexpres-
sion results in a loss of wing tissues, rather than promoting
novel wing development in other discs [1,3,9]. So sd does
not have the characteristics of a wing-specific switch.
Nevertheless, sd does encode a DNA-binding protein:
specifically, Sd is a member of the TEA/ATTS class of
transcription factors, homologous to the human protein
‘transcription enhancer factor 1’ (TEF-1), which binds to
the simian virus 40 (SV40) enhancer [9–11]. 
It now emerges that Sd is required for Vg to exert its
effects. Thus, misexpression of Vg results in ectopic wing
tissue only in places where Sd is also present [1,2]. This
Figure 1
Wing development in Drosophila. (a) Three
stages are shown: late larval imaginal disc;
everting pupal disc (rotated 90° with respect
to the larval disc); and adult wing, with
positions of sensory organs (red) and wing
veins (blue) indicated. (b) Expression patterns
of vestigial (purple) and D-SRF/blistered
(green) in the wing disc; the darker shading
delimits the expression from the specific
enhancers depicted in Figure 2.
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correlates with the activation in these ectopic locations of
‘wing’ target genes, such as D-SRF/blistered (which is
needed for the correct morphology of the intervein cells in
the wing, see Figure 1) [1,3]. Conversely, when sd is
removed, expression of D-SRF/blistered in the wing is
abolished. But sd and vg are normally co-expressed in the
wing and their expression is mutually dependent [12], so
it was important to test whether sd is still required for vg
function when this interdependence is circumvented by
expressing Vg under heterologous regulation. Even under
such conditions, expression of D-SRF/blistered and other
target genes was abolished in sd mutant cells [1,3]. These
observations suggest that Sd functions in parallel with Vg
to coordinate the expression of wing genes such as
D-SRF/blistered.
The parallel effects of Sd and Vg are explained by the fact
that the two proteins interact directly, as shown by recent
in vitro and yeast two-hybrid experiments [1–3]. In cell
culture assays, Vg acts synergistically with Sd to stimulate
expression from D-SRF/blistered and vg enhancers [1].
Deletion of the Sd-interaction domain from Vg renders it
unable to activate wing target genes in vivo or to promote
wing development [3]. Thus the two proteins together
form a transcriptional activator, in which Sd provides the
DNA-binding component and Vg is thought to provide the
transcriptional activation domain, although this has not
been formally proven. Consistent with this view, Sd
binding sites are present in the wing-specific enhancers of
target genes such as D-SRF/blistered, and wing expression
is abolished when these sites are mutated [1,13]. The
same enhancers also contain target sites for the effectors of
specific signalling pathways — such as Cubitus interruptus
(Ci), the transcription factor at the end of the Hedgehog
signalling pathway, in the case of D-SRF/blistered — and it
is proposed that these factors act in combination with
Sd–Vg [1]. The idea is that the precise combination of sig-
nalling effectors and Sd–Vg that impinges on a particular
target gene determines its specific pattern of expression.
The wing transcriptional enhancers are thus elegant
examples of combinatorial gene regulation, with the
Sd–Vg complex being the component that promotes wing-
specific expression (Figure 2). One intriguing aspect of
this model is that the specificity in the Sd–Vg complex
does not reside in the DNA-binding component Sd, but in
the restricted expression of Vg. If Sd interacts with alter-
native coactivators in other discs/tissues, as seems likely
from the variety of phenotypes detected in Sd mutants
[9], there must be a mechanism for targeting different
Sd–coactivator complexes to specific enhancers. 
One possibility is that the sequence-specificity of DNA
recognition by Sd is augmented by the coactivator; this
could be achieved, for example, if Vg itself contacts some
bases or if it alters the stability of Sd–DNA interactions.
There are many examples of cofactors that confer added
DNA-binding specificity on a complex by contacting the
DNA, as in the interactions of SAP1 and ELK-1 with serum
response factor [14]. Furthermore, in the case of some het-
erodimers between Hox proteins and their Pbx–Extradenti-
cle cofactors, the interaction induces a change in the
binding affinity/specificity of the Hox protein [15]. 
Clearly, the Sd protein can bind to sites in the relevant
enhancers in the absence of Vg [1], but so far there has been
no comparison with the binding of the Sd–Vg complex to
see whether the affinity is altered by the presence of the
coactivator. If Vg does not affect the DNA-binding proper-
ties of Sd, it would suggest the alternative that the topology
of the Sd–Vg complex is critical for conferring specificity:
that is, that a combination of Sd with a different coactivator
would not be able to cooperate effectively with the other
transcription factors bound to the wing enhancers. Given
the apparently modular nature of enhancers, this seems a
less likely explanation, but resolution of the issue must
await the identification of additional Sd coactivators.
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Figure 2
A model for combinatorial regulation of wing-specific enhancers by
Sd—Vg and transcription factors at the ends of signalling pathways
(see [3] and text for details).
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A further question to be resolved is whether there are
indeed other partners for Sd and, if so, whether they
resemble Vg. The sd mutant phenotypes include defects
in sensory organ development and sd transcripts can be
detected in both peripheral and central nervous system
[9]. Perhaps Sd has a different partner in these tissues, but
so far no proteins similar to Vg have been identified in
flies or vertebrates, although there is evidence that tissue-
specific factors associate with the human TEF-1. Expres-
sion of vg itself is also not unique to the wing; although Vg
cannot be detected in other imaginal discs, vg is expressed
in a subset of somatic muscles [16]. There is no evidence
for sd expression in these cells, so presumably Vg interacts
with another DNA-binding protein that will direct the
complex to a distinct set of target genes. This emphasises
that it is the Sd–Vg combination that directs wing devel-
opment, rather than Vg per se.
A comparison between different wing-specific enhancers
gives rise to a simple model of combinatorial regulation
whereby Sd–Vg acts in combination with different sig-
nalling inputs (Figure 2). Thus, an enhancer combining
Sd–Vg and Ci binding sites gives a stripe of expression
adjacent to the posterior compartment where Hedgehog is
expressed [6]. When a different site is substituted for that
of Ci, the pattern of expression is changed: thus in the
example illustrated in Figure 2, the new binding site is for
Suppressor of Hairless (Su(H)) and the expression pattern
is changed to a dorsal–ventral stripe, reflecting the activity
of the Notch pathway that operates through this DNA-
binding protein. Likewise, an enhancer containing a
binding site for Mad–Medea, the effector of the Deca-
pentaplegic pathway, gives rise to broader expression
throughout the wing field [17]. 
A model of this kind, involving the combined action of
signalling pathways with tissue-specific elements, has also
been proposed from studies of Dpp target genes in the
embryo, where the transcription factor Mad–Medea
combines with complexes such as Labial–Extradenticle in
the endoderm or Tinman in the mesoderm [18,19]. It is
clear, however, that more factors will be involved; for
example the enhancer that responds to Mad–Medea and
Sd–Vg is not active throughout the wing field, there is a
domain where it is silent. Furthermore, many of the wing
enhancers are also targets for Ultrabithorax [20], which is
required to repress wing-specific genes in the haltere. As
the relationships between these different components are
mapped onto the DNA of enhancers for genes such as
D-SRF/blistered, we begin to get a picture of the molecular
code that specifies morphologically distinct structures,
such as wings, eyes and legs.
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